Real-World Outcomes of Ruxolitinib for Polycythemia Vera

被引:0
|
作者
Coltoff, Alexander
Tremblay, Douglas
Kremyanskaya, Marina
Hoffman, Ronald
Mascarenhas, John
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2926
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Real-World Outcomes of Ruxolitinib Treatment for Polycythemia Vera
    Coltoff, Alexander
    Mesa, Ruben
    Gotlib, Jason
    Shulman, Jessica
    Rampal, Raajit K.
    Siwoski, Olivia
    Yacoub, Abdulraheem
    Moliterno, Alison
    Yang, Anna
    Braunstein, Evan
    Gerds, Aaron T.
    Hobbs, Gabriela S.
    Winton, Elliott F.
    Goel, Swati
    Wadleigh, Martha
    Tremblay, Douglas
    Moshier, Erin
    Mascarenhas, John
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 (10): : 697 - +
  • [2] The Real-World Treatment of Polycythemia Vera: Adherence to Treatment Guidelines and Outcomes
    Chornenki, Nicholas L. Jackson
    Chai-Adisaksopha, Chatree
    Siegal, Deborah M.
    Hillis, Christopher M.
    [J]. BLOOD, 2017, 130
  • [3] Real-World Dosing Patterns of Ruxolitinib in Patients with Polycythemia Vera Who are Resistant to or Intolerant of Hydroxyurea
    Altomare, Ivy
    Nguyen, Anna
    Parasuraman, Shreekant
    Paranagama, Dilan
    Kish, Jonathan K.
    Lord, Kevin
    Colucci, Philomena
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S326 - S327
  • [4] Real-World Dosing Patterns of Ruxolitinib in Patients with Polycythemia Vera Who Are Resistant to or Intolerant of Hydroxyurea
    Altomare, Ivy
    Nguyen, Anna
    Parasuraman, Shreekant
    Paranagama, Dilan
    Kish, Jonathan K.
    Lord, Kevin
    Colucci, Philomena
    [J]. BLOOD, 2019, 134
  • [5] Real-World Dosing Patterns of Ruxolitinib in Patients With Polycythemia Vera Who Are Resistant to or Intolerant of Hydroxyurea
    Altomare, Ivy
    Parasuraman, Shreekant
    Paranagama, Dilan
    Kish, Jonathan
    Lord, Kevin
    Yu, Jingbo
    Colucci, Philomena
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (11): : E915 - E921
  • [6] The real-world outcomes of treating Polycythemia Vera: Physician adherence to treatment guidelines
    Chornenki, Nicholas L. Jackson
    Chai-Adisaksopha, Chatree
    Leonh, Darryl P.
    Siegal, Deborah M.
    Hillis, Christopher M.
    [J]. LEUKEMIA RESEARCH, 2018, 70 : 62 - 66
  • [7] Effect of durable hematocrit control and minimal thrombotic risk in real-world polycythemia vera patients treated with ruxolitinib
    Chojecki, Aleksander Lech
    Boselli, Danielle
    Dortilus, Allison
    Hamadeh, Issam
    Begley, Stephanie
    Chen, Tommy
    Bose, Rupali
    Podoltsev, Nikolai Alexandrovich
    Zeidan, Amer Methqal
    Balmaceda, Nicole Baranda
    Yacoub, Abdulraheem
    Ai, Jing
    Knight, Thomas Gregory
    Ragon, Brittany K.
    Shah, Nilay Arvind
    Sanikommu, Srinivasa
    Symanowski, James Thomas
    Mesa, Ruben A.
    Grunwald, Michael Richard
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [8] Real-world analysis of main clinical outcomes in patients with polycythemia vera treated with ruxolitinib or best available therapy after developing resistance/intolerance to hydroxyurea
    Alvarez-Larran, Alberto
    Garrote, Marta
    Ferrer-Marin, Francisca
    Perez-Encinas, Manuel
    Mata-Vazquez, M. Isabel
    Bellosillo, Beatriz
    Arellano-Rodrigo, Eduardo
    Gomez, Montse
    Garcia, Regina
    Garcia-Gutierrez, Valentin
    Gasior, Mercedes
    Cuevas, Beatriz
    Angona, Anna
    Gomez-Casares, Maria Teresa
    Martinez, Clara M.
    Magro, Elena
    Ayala, Rosa
    del Orbe-Barreto, Rafael
    Perez-Lopez, Raul
    Fox, Maria Laura
    Raya, Jose-Maria
    Guerrero, Lucia
    Garcia-Hernandez, Carmen
    Caballero, Gonzalo
    Murillo, Ilda
    Xicoy, Blanca
    Ramirez, M. Jose
    Carreno-Tarragona, Gonzalo
    Hernandez-Boluda, Juan Carlos
    Pereira, Arturo
    [J]. CANCER, 2022, 128 (13) : 2441 - 2448
  • [9] THERAPY OF THE POLYCYTHEMIA VERA WITH RUXOLITINIB
    Melikyan, A. L.
    Subortseva, I. N.
    Gilyazitdinova, E. A.
    Kovrigina, A. M.
    Sudarikov, A. B.
    Abdullaev, A. O.
    [J]. GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2017, 62 (04): : 229 - 232
  • [10] Ruxolitinib for treatment of polycythemia vera
    Cherington, Chad C.
    Gowin, Krisstina L.
    Mesa, Ruben A.
    [J]. EXPERT OPINION ON ORPHAN DRUGS, 2015, 3 (09): : 1085 - 1096